Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium

Detalles Bibliográficos
Autores principales: Kaul, Pallvi, Singh, Mahendra Pal, Pasricha, Rajesh, Garg, Pankaj Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269919/
https://www.ncbi.nlm.nih.gov/pubmed/32513628
http://dx.doi.org/10.1016/j.oraloncology.2020.104839
_version_ 1783541826208137216
author Kaul, Pallvi
Singh, Mahendra Pal
Pasricha, Rajesh
Garg, Pankaj Kumar
author_facet Kaul, Pallvi
Singh, Mahendra Pal
Pasricha, Rajesh
Garg, Pankaj Kumar
author_sort Kaul, Pallvi
collection PubMed
description
format Online
Article
Text
id pubmed-7269919
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72699192020-06-05 Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium Kaul, Pallvi Singh, Mahendra Pal Pasricha, Rajesh Garg, Pankaj Kumar Oral Oncol Article Elsevier Ltd. 2020-08 2020-06-04 /pmc/articles/PMC7269919/ /pubmed/32513628 http://dx.doi.org/10.1016/j.oraloncology.2020.104839 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kaul, Pallvi
Singh, Mahendra Pal
Pasricha, Rajesh
Garg, Pankaj Kumar
Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium
title Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium
title_full Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium
title_fullStr Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium
title_full_unstemmed Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium
title_short Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium
title_sort methotrexate based oral chemotherapy for advanced oral cancer during covid-19 pandemic: another option in the therapeutic armamentarium
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269919/
https://www.ncbi.nlm.nih.gov/pubmed/32513628
http://dx.doi.org/10.1016/j.oraloncology.2020.104839
work_keys_str_mv AT kaulpallvi methotrexatebasedoralchemotherapyforadvancedoralcancerduringcovid19pandemicanotheroptioninthetherapeuticarmamentarium
AT singhmahendrapal methotrexatebasedoralchemotherapyforadvancedoralcancerduringcovid19pandemicanotheroptioninthetherapeuticarmamentarium
AT pasricharajesh methotrexatebasedoralchemotherapyforadvancedoralcancerduringcovid19pandemicanotheroptioninthetherapeuticarmamentarium
AT gargpankajkumar methotrexatebasedoralchemotherapyforadvancedoralcancerduringcovid19pandemicanotheroptioninthetherapeuticarmamentarium

Ejemplares similares